Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30134% above fair value
$26.14−0.21 (-0.80%)
Close on Nov 13, 2026Market cap $1.00BP/E –Yield –
Ceribell price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Ceribell's price to sales ratio was 10.4× on Nov 11, 2026, against 7.6× a year earlier. Over the last 2 years it ranged from 2.2× to 12.7×, with a median of 7.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.4× | +0.6 |
| 2025 | Dec 31, 2025 | 9.8× | +7.3 |
| 2024 | Dec 31, 2024 | 2.5× | – |
See a number that looks wrong?